User Experiences of Pharmacogenomic Testing and Opinions among Psychiatry Patients
Pharmacogenomic testing (PGx) is a tool used to guide physicians in selecting an optimal medication for clients based on their genetic profile. The objective of this qualitative study is to understand patients’ experiences with PGx testing as well as their opinions regarding the clinical adoption of...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-12-01
|
| Series: | Journal of Personalized Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4426/14/1/22 |
| _version_ | 1797343282354716672 |
|---|---|
| author | Catherine R. Virelli Mahbod Ebrahimi Ayeshah G. Mohiuddin Julia Tomasi Amanda J. Lisoway Deanna Herbert Victoria S. Marshe Sean A. Kidd Joseph Ferenbok James L. Kennedy |
| author_facet | Catherine R. Virelli Mahbod Ebrahimi Ayeshah G. Mohiuddin Julia Tomasi Amanda J. Lisoway Deanna Herbert Victoria S. Marshe Sean A. Kidd Joseph Ferenbok James L. Kennedy |
| author_sort | Catherine R. Virelli |
| collection | DOAJ |
| description | Pharmacogenomic testing (PGx) is a tool used to guide physicians in selecting an optimal medication for clients based on their genetic profile. The objective of this qualitative study is to understand patients’ experiences with PGx testing as well as their opinions regarding the clinical adoption of such tests in psychiatry. A focus group was conducted to assess the needs of clients who had experience using a PGx test. Participants were recruited from a large study on PGx testing that offered physicians an opportunity to use PGx reports to guide psychotropic prescriptions. The focus group discussions were recorded, transcribed, and coded using NVivo to identify core themes. A total of 11 people participated in the focus group. Our analysis revealed that many participants were in favour of implementing PGx testing in psychiatric practice, and all expressed important considerations for patient-centred optimization of PGx testing. The main themes captured were: education and awareness among clinicians, cost considerations, PGx results-sharing and accessibility, and prospective benefits. The results of this study suggest that patients are keen to see PGx testing in widespread clinical care, but they report important opportunities to improve knowledge mobilization of PGx testing. |
| first_indexed | 2024-03-08T10:45:26Z |
| format | Article |
| id | doaj.art-923ef9e709334b0283d1fd195e59ee35 |
| institution | Directory Open Access Journal |
| issn | 2075-4426 |
| language | English |
| last_indexed | 2024-03-08T10:45:26Z |
| publishDate | 2023-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Personalized Medicine |
| spelling | doaj.art-923ef9e709334b0283d1fd195e59ee352024-01-26T17:19:18ZengMDPI AGJournal of Personalized Medicine2075-44262023-12-011412210.3390/jpm14010022User Experiences of Pharmacogenomic Testing and Opinions among Psychiatry PatientsCatherine R. Virelli0Mahbod Ebrahimi1Ayeshah G. Mohiuddin2Julia Tomasi3Amanda J. Lisoway4Deanna Herbert5Victoria S. Marshe6Sean A. Kidd7Joseph Ferenbok8James L. Kennedy9Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON M6J 1H4, CanadaTanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON M6J 1H4, CanadaTanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON M6J 1H4, CanadaTanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON M6J 1H4, CanadaTanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON M6J 1H4, CanadaTanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON M6J 1H4, CanadaDepartment of Neurology, Columbia University, New York, NY 10027, USATanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON M6J 1H4, CanadaLaboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, CanadaTanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON M6J 1H4, CanadaPharmacogenomic testing (PGx) is a tool used to guide physicians in selecting an optimal medication for clients based on their genetic profile. The objective of this qualitative study is to understand patients’ experiences with PGx testing as well as their opinions regarding the clinical adoption of such tests in psychiatry. A focus group was conducted to assess the needs of clients who had experience using a PGx test. Participants were recruited from a large study on PGx testing that offered physicians an opportunity to use PGx reports to guide psychotropic prescriptions. The focus group discussions were recorded, transcribed, and coded using NVivo to identify core themes. A total of 11 people participated in the focus group. Our analysis revealed that many participants were in favour of implementing PGx testing in psychiatric practice, and all expressed important considerations for patient-centred optimization of PGx testing. The main themes captured were: education and awareness among clinicians, cost considerations, PGx results-sharing and accessibility, and prospective benefits. The results of this study suggest that patients are keen to see PGx testing in widespread clinical care, but they report important opportunities to improve knowledge mobilization of PGx testing.https://www.mdpi.com/2075-4426/14/1/22pharmacogenomicspharmacogeneticsmental healthpersonalized medicinefocus group |
| spellingShingle | Catherine R. Virelli Mahbod Ebrahimi Ayeshah G. Mohiuddin Julia Tomasi Amanda J. Lisoway Deanna Herbert Victoria S. Marshe Sean A. Kidd Joseph Ferenbok James L. Kennedy User Experiences of Pharmacogenomic Testing and Opinions among Psychiatry Patients Journal of Personalized Medicine pharmacogenomics pharmacogenetics mental health personalized medicine focus group |
| title | User Experiences of Pharmacogenomic Testing and Opinions among Psychiatry Patients |
| title_full | User Experiences of Pharmacogenomic Testing and Opinions among Psychiatry Patients |
| title_fullStr | User Experiences of Pharmacogenomic Testing and Opinions among Psychiatry Patients |
| title_full_unstemmed | User Experiences of Pharmacogenomic Testing and Opinions among Psychiatry Patients |
| title_short | User Experiences of Pharmacogenomic Testing and Opinions among Psychiatry Patients |
| title_sort | user experiences of pharmacogenomic testing and opinions among psychiatry patients |
| topic | pharmacogenomics pharmacogenetics mental health personalized medicine focus group |
| url | https://www.mdpi.com/2075-4426/14/1/22 |
| work_keys_str_mv | AT catherinervirelli userexperiencesofpharmacogenomictestingandopinionsamongpsychiatrypatients AT mahbodebrahimi userexperiencesofpharmacogenomictestingandopinionsamongpsychiatrypatients AT ayeshahgmohiuddin userexperiencesofpharmacogenomictestingandopinionsamongpsychiatrypatients AT juliatomasi userexperiencesofpharmacogenomictestingandopinionsamongpsychiatrypatients AT amandajlisoway userexperiencesofpharmacogenomictestingandopinionsamongpsychiatrypatients AT deannaherbert userexperiencesofpharmacogenomictestingandopinionsamongpsychiatrypatients AT victoriasmarshe userexperiencesofpharmacogenomictestingandopinionsamongpsychiatrypatients AT seanakidd userexperiencesofpharmacogenomictestingandopinionsamongpsychiatrypatients AT josephferenbok userexperiencesofpharmacogenomictestingandopinionsamongpsychiatrypatients AT jameslkennedy userexperiencesofpharmacogenomictestingandopinionsamongpsychiatrypatients |